| Date Filed | Type | Description |
| 03/24/2017 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 02/10/2016 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.9% stake in Allergan plc |
| 03/23/2015 |
SC 13D/A
| Pershing Square reports a 0% stake in ALLERGAN, INC. |
| 03/19/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/19/2015 |
4
| INGRAM DOUGLAS S (President) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| Dunsire Deborah (Director) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| Jones Trevor M (Director) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| Proctor Timothy D (Director) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| LAVIGNE LOUIS J JR (Director) has filed a Form 4 on ALLERGAN INC|
Txns:
| Disposed/sold 2,920 shares
@ $0
Disposed/sold 15,228 shares
@ $0 |
|
| 03/19/2015 |
4
| McDonnell Peter J (Director) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| TERMEER HENRI A (Director) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| RAY RUSSELL T (Director) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| GALLAGHER MICHAEL R (Director) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| Diradoorian Raymond H (EVPGlobal Technical Operations) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| Hindman James M. (EVP, Finance & Bus. Dev., CFO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Gifted 2,174 shares
@ $0
Granted 11,274 shares
@ $0
Disposed/sold 32,320 shares
@ $0
Disposed/sold 6,495 shares
@ $0
Disposed/sold 6,045 shares
@ $0
Disposed/sold 18,000 options to buy
@ $55.98, valued at
$1M
Disposed/sold 19,000 options to buy
@ $58.55, valued at
$1.1M
Disposed/sold 17,600 options to buy
@ $64.47, valued at
$1.1M
Disposed/sold 22,300 options to buy
@ $40.16, valued at
$895.6k
Disposed/sold 18,950 options to buy
@ $59.13, valued at
$1.1M
Disposed/sold 19,000 options to buy
@ $75.58, valued at
$1.4M
|
|
| 03/19/2015 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC |
| 03/19/2015 |
4
| PINKSTON ARNOLD A (EVP and General Counsel) has filed a Form 4 on ALLERGAN INC|
Txns:
| Granted 6,342 shares
@ $0
Disposed/sold 6,342 shares
@ $0
Disposed/sold 18,000 options to buy
@ $84.4, valued at
$1.5M
Disposed/sold 35,000 options to buy
@ $87.91, valued at
$3.1M
Disposed/sold 38,000 options to buy
@ $105.87, valued at
$4M
Disposed/sold 32,789 options to buy
@ $125.07, valued at
$4.1M
Disposed/sold 285 restricted stock units
@ $0 |
|
| 03/19/2015 |
4
| Sherman Scott D (Executive Vice President, HR) has filed a Form 4 on ALLERGAN INC|
Txns:
| Disposed/sold 1,644 shares
@ $0
Disposed/sold 4,045 shares
@ $0
Granted 6,342 shares
@ $0
Disposed/sold 6,349 shares
@ $0
Disposed/sold 3,000 options to buy
@ $73.04, valued at
$219.1k
Disposed/sold 20,000 options to buy
@ $75.58, valued at
$1.5M
Disposed/sold 35,000 options to buy
@ $87.91, valued at
$3.1M
Disposed/sold 38,000 options to buy
@ $105.87, valued at
$4M
Disposed/sold 32,789 options to buy
@ $125.07, valued at
$4.1M
Disposed/sold 238 restricted stock units
@ $0 |
|
| 03/19/2015 |
4
| BARLOW JAMES F (SR. VP, Corp. Controller (PAO)) has filed a Form 4 on ALLERGAN INC |
| 03/18/2015 |
8-K
| Quarterly results |
| 03/16/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/12/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/12/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/11/2015 |
4
| Proctor Timothy D (Director) has filed a Form 4 on ALLERGAN INC |
| 03/11/2015 |
4
| Jones Trevor M (Director) has filed a Form 4 on ALLERGAN INC |
| 03/11/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/11/2015 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits|
Docs:
|
"Actavis and Allergan Shareholders Approve Proposals Related to Actavis' Planned Acquisition of Allergan DUBLIN, Ireland & IRVINE, Calif. - March 10, 2015 - Actavis plc and Allergan, Inc. announced that, at shareholder meetings held today, all proposals related to Actavis' planned acquisition of Allergan were approved by both Actavis' and Allergan's shareholders. Actavis' and Allergan's shareholder approvals satisfy certain conditions to the closing of the transaction. The closing of the transaction is expected to occur late in the first quarter or early in the second quarter of 2015, subject to the satisfaction or waiver of certain regulatory approvals and other customary closing conditions. 1 About Actavis About Actavis plc , headquartered in Dublin, Ireland, is a unique specialty pharmac..." |
|
| 03/10/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/05/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/05/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/03/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/02/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/02/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
|